Scientific Hypotheses – Michigan Paranormal Encounters http://michiganparanormalencounters.com/ Tue, 21 Jun 2022 06:05:36 +0000 en-US hourly 1 https://wordpress.org/?v=5.9.3 https://michiganparanormalencounters.com/wp-content/uploads/2021/06/icon-2.png Scientific Hypotheses – Michigan Paranormal Encounters http://michiganparanormalencounters.com/ 32 32 COVID-19 most likely leaked from Wuhan lab: WHO chief | The Weather Channel – Articles from The Weather Channel https://michiganparanormalencounters.com/covid-19-most-likely-leaked-from-wuhan-lab-who-chief-the-weather-channel-articles-from-the-weather-channel/ Tue, 21 Jun 2022 06:05:36 +0000 https://michiganparanormalencounters.com/covid-19-most-likely-leaked-from-wuhan-lab-who-chief-the-weather-channel-articles-from-the-weather-channel/ Representative picture (IANS) Just days after saying the COVID lab leak theory needed “further investigation”, the head of the World Health Organization (WHO) privately told a senior European politician that the pandemic originated in the infamous famous Chinese laboratory in Wuhan, according to a report. According to WHO Director-General Tedros Adhanom Ghebreyesus, the most likely […]]]>

Representative picture

(IANS)

Just days after saying the COVID lab leak theory needed “further investigation”, the head of the World Health Organization (WHO) privately told a senior European politician that the pandemic originated in the infamous famous Chinese laboratory in Wuhan, according to a report.

According to WHO Director-General Tedros Adhanom Ghebreyesus, the most likely explanation was a catastrophic accident at a lab in Wuhan, where infections first spread in late 2019, the Daily Mail reported.

However, the UN health agency publicly maintains that “all hypotheses remain on the table”.

Initially, the WHO was criticized for its deferential approach to China, but in the absence of convincing evidence of “zoonotic” spread, the global agency is now taking a more neutral public stance, the report said.

“We don’t yet have answers as to where it came from or how it entered the human population. Understanding the origins of the virus is very important scientifically to prevent future epidemics and pandemics,” Ghebreyesus reportedly said. this month.

“But morally, we also owe it to all those who have suffered and died and their families. The longer it takes, the more difficult it becomes. We need to step up and act with a sense of urgency.

“All hypotheses must remain on the table until we have evidence that allows us to rule out certain hypotheses. This makes it all the more urgent that this scientific work be separated from politics,” he said. declared.

The origin of COVID-19 has remained the subject of political and scientific debate, with scientists and politicians around the world claiming that the coronavirus jumped into people from bats or was leaked from a laboratory. The WHO, in its initial assessment, said it was “extremely unlikely” that COVID-19 spread to humans from a lab, but the agency later admitted flaws in it. the report and ordered a new investigation.

In a recent report by the Scientific Advisory Group on the Origins of New Pathogens (SAGO), the expert group created in 2021 to research the causes of the pandemic by the WHO shared that “key pieces of data are not still available for a full understanding of how the COVID-19 pandemic began.”

The report, however, suggests the virus likely originated in animals, likely bats. But he also didn’t rule out the possibility of a lab leak, citing a lack of clear data.

Meanwhile, WHO experts, including the SAGO panel, have argued that China is not cooperating with the original COVID-19 probe. Ghebreyesus also called for “the full cooperation of all countries, including China, where the first cases of SARS-CoV-2 were reported.”

China, for its part, has from the start protested that the lab leak claims were just a “conspiracy theory”. He also claimed that the virus originated in the United States.

**

The above article was published by a news agency with minimal changes to the title and text.

]]>
WHO chief ‘believes Covid DID leaked from Wuhan lab’ after ‘catastrophic accident’ in 2019 https://michiganparanormalencounters.com/who-chief-believes-covid-did-leaked-from-wuhan-lab-after-catastrophic-accident-in-2019/ Sat, 18 Jun 2022 21:01:56 +0000 https://michiganparanormalencounters.com/who-chief-believes-covid-did-leaked-from-wuhan-lab-after-catastrophic-accident-in-2019/ WHO chief ‘believes Covid DID leaked from Wuhan lab’ after ‘catastrophic accident’ in 2019 despite public maintaining ‘all assumptions remain on the table’ Managing director Tedros Adhanom entrusted to a senior European official: source The Mail on Sunday first revealed concerns about the Wuhan Institute of Virology The global death toll from the Covid pandemic […]]]>

WHO chief ‘believes Covid DID leaked from Wuhan lab’ after ‘catastrophic accident’ in 2019 despite public maintaining ‘all assumptions remain on the table’

  • Managing director Tedros Adhanom entrusted to a senior European official: source
  • The Mail on Sunday first revealed concerns about the Wuhan Institute of Virology
  • The global death toll from the Covid pandemic is now estimated at over 18 million
  • WHO initially called scare lab leak a ‘conspiracy theory’, accepting China’s story

The head of the World Health Organization privately believes the Covid pandemic started following a leak from a Chinese lab, according to a senior government source.

While publicly the group maintains that “all hypotheses remain on the table” on the origins of Covid, the source specifies that Tedros Adhanom Ghebreyesus, director general of the World Health Organization (WHO), had recently confided to a senior European politician that the most likely explanation was a catastrophic accident at a lab in Wuhan, where infections first spread in late 2019.

The Mail on Sunday first revealed concerns within Western intelligence over the Wuhan Institute of Virology, where scientists were handling coronaviruses taken from bats in caves nearly 1,000 miles away – the same caves where Covid-19 is believed to have originated – in April 2020. The worldwide death toll from the Covid pandemic is now estimated to have reached over 18 million.

Researchers work in a lab at the Wuhan Institute of Virology, where Covid was first discovered

The WHO was initially criticized for its deferential approach to China in the face of the pandemic, as well as its willingness to accept Beijing’s protests that the lab leak claims were just a ” conspiracy theory”.

However, in the absence of any convincing evidence of ‘zoonotic’ spread – the process by which a virus jumps from animals to humans – he is now taking a more neutral public stance.

Dr Tedros updated member states on the pandemic this month, admitting: ‘We don’t yet have answers as to where it came from or how it entered the human population.

“Understanding the origins of the virus is very important scientifically to prevent future epidemics and pandemics.

“But morally, we also owe it to all those who suffered and died and their families. The longer it takes, the more difficult it becomes. We need to step up and act with a sense of urgency.

“All hypotheses must remain on the table until we have evidence that allows us to rule out certain hypotheses. This makes it all the more urgent that this scientific work be separated from politics. The way to prevent the politicization is for countries to share data and samples transparently and without interference from any government.The only way this scientific work can progress successfully is with the full cooperation of all countries, including China, where the first cases of SARS-CoV-2 have been reported.

The Mail on Sunday first revealed concerns about the region's Institute of Virology in 2020

The Mail on Sunday first revealed concerns about the region’s Institute of Virology in 2020

It has been suggested that Covid

It has been suggested that Covid ‘could have easily escaped while being analysed’ by scientists

Last year, the WHO established the Scientific Advisory Group on the Origins of New Pathogens (Sago) to define the studies that would be needed to identify the origins of SARS-CoV-2 – as Covid is scientifically known – and to “to create a global framework for studying the origin of emerging and re-emerging pathogens”.

An original WHO-led outbreak investigation was fiercely resisted by China, leading to a report concluding that the SARS-CoV-2 virus was likely transmitted to humans by a bat via another unidentified species.

But after 14 countries, including the UK, US and Australia, criticized its findings as heavily compromised, Dr Tedros admitted the report’s flaws and ordered the new process.

WHO Director-General Tedros Adhanom reluctant to openly criticize China

WHO Director-General Tedros Adhanom reluctant to openly criticize China

The government has taken a cautious approach to assigning blame to Covid – something Chinese skeptics attribute to fear of offending Beijing.

However, US intelligence has placed the secret Wuhan lab at the center of their analysis.

Former US Secretary of State Mike Pompeo claimed workers at the institute fell ill with Covid-like symptoms in the fall of 2019 – weeks before the alarm was raised, and said that in As part of military projects, its scientists were experimenting with a bat coronavirus very similar to the one that causes Covid.

A WHO spokesperson said: “Dr Tedros has consistently said that all hypotheses remain on the table as scientists continue their work.”

]]>
Unexplainable Podcast: 7 Solar System Mysteries Scientists Haven’t Solved Yet https://michiganparanormalencounters.com/unexplainable-podcast-7-solar-system-mysteries-scientists-havent-solved-yet/ Thu, 16 Jun 2022 11:00:00 +0000 https://michiganparanormalencounters.com/unexplainable-podcast-7-solar-system-mysteries-scientists-havent-solved-yet/ The next time you look at a bright full moon, think about this: no one knows exactly where the moon came from. “We have no idea why the moon is here,” science writer Rebecca Boyle said on Inexplicable – Vox’s podcast that explores big mysteries, unanswered questions and everything in between we learn by diving […]]]>

The next time you look at a bright full moon, think about this: no one knows exactly where the moon came from.

“We have no idea why the moon is here,” science writer Rebecca Boyle said on Inexplicable – Vox’s podcast that explores big mysteries, unanswered questions and everything in between we learn by diving into the unknown. “I think for a lot of people [the moon] is taken for granted, it’s that mundane stuff, and galaxies, nebulae, stars, and planets are more intriguing.

It’s true that some of the most epic questions in science lie in the outer reaches of space – how and when did the first galaxies form, what happens inside a hole? black – but equally epic questions exist here, in our celestial neighborhood, in our own solar system.

To explore our own solar system – the moons and planets it contains – is to better understand what is possible in the far reaches of the universe. Everything we find or discover in our own cosmic backyard will help us understand what is possible in the larger universe. If evidence of ancient life is found on a hostile world like Mars, we might better understand just how common life might be in other solar systems. If we understand how a possibly once vibrant world like Venus fell to ruin, we might understand how often similar planets around other stars die in an apocalypse.

The solar system’s most provocative mysteries help us understand why we’re here, how long we have left, and what we might be leaving behind. Here are some of the solar system mysteries we encountered on Inexplicable.

For more mysteries, listen and follow Inexplicable wherever you listen to podcasts.


What killed Venus?

The clouds of Venus captured in 1974 by NASA’s Mariner 10 spacecraft.
Nasa

“Hellscape” is the most appropriate word to describe the surface of Venus, the second planet from the sun. At 900 degrees Fahrenheit, it’s the hottest planet in the solar system, thanks to an atmosphere almost entirely made up of carbon dioxide, which generates a very strong greenhouse effect. Clouds made of highly corrosive sulfuric acid are draped over a volcanic landscape of razor-sharp volcanic rock. The pressure on the surface of Venus is about 92 times greater than what you would feel at sea level on Earth.

Yet some scientists suspect Venus is Earth-like, with an ocean of liquid water like those that support life on our planet. This raises an existential question for life on Earth.

“Venus and Earth are planetary sisters,” says Robin George Andrews, volcanologist and author of Super Volcanoes: What They Reveal About Earth and Worlds Beyond. “They were made at the same time and made of the same material, but Venus is apocalyptic and awful in every way possible. Earth is a paradise. So why do we have a paradise next to a lost paradise?

There are two main assumptions. The first is that the sun baked Venus to death. The other is that volcanoes did it.

Further reading: Venus could have been a paradise but turned into a hellish landscape. Earthlings, be careful.


Where the hell did the moon come from?

This view from the Apollo 11 spacecraft shows Earth rising above the moon’s horizon.
HUM Images/Universal Images Group

Before the moon landings, scientists thought they knew how the moon was formed. The prevailing theory was that it formed much like the planets: bits of matter left over from the formation of the sun, coming together. But then Apollo astronauts brought back samples from the lunar surface, and those rocks told an entirely different story.

“Geologists had discovered that the moon was covered with a particular type of rock called anorthosite”, Inexplicable says senior producer Meradith Hoddinott on the show. “Glittering, shining and reflective, it is the rock that makes the white moon shine in the night sky. And at the time, it was thought, this rock could only form in a very specific way. Magma.”

But magma means the moon must have formed in some kind of epic cataclysm. “Something that poured so much energy into the moon that it literally melted,” says Hoddinott. Scientists don’t know exactly how it all happened. But each scenario is a cinematic story of fiery apocalyptic proportions.

Further reading: How Apollo’s moon rocks reveal the epic story of the cosmos


Is there anything alive in the human shit left on the moon?

A bag of astronaut trash left on the moon in 1969.
Nasa

During the Apollo missions to the Moon, astronauts traveled to the Moon and, to save weight for the return to Earth, they dumped their trash behind them. In all the Apollo missions, the astronauts left 96 Bags human waste on the moon, and they pose a fascinating astrobiological question.

Human waste – and especially feces – is teeming with microbial life. With the Apollo moon landings, we took microbial life to Earth into the most extreme environment it has ever been in. Which means littering on the moon represents a natural, albeit unintended, experience.

The question the experiment could answer: how resilient is life to the harsh environment of the moon? And besides, if microbes can survive on the moon, can they survive interplanetary or interstellar travel? If they can survive, then it may be possible for life to spread from planet to planet, riding on the backs of asteroids or other space junk.

Further reading: Apollo astronauts left their poo on the moon. We have to go back for this shit.


Was there an advanced civilization on Earth before humans?

Illustration of the supercontinent Gondwana, a landmass that formed entirely around 550 million years ago and began to break up around 180 million years ago.
Scientific photo Libra/Getty Images

Many scientists have long wondered: is there intelligent life in the depths of space? But climatologist Gavin Schmidt and astrophysicist Adam Frank have another question: Was there intelligent life deep within Earth’s history? Could we find evidence of an advanced non-human civilization that lived perhaps hundreds of millions of years ago, buried in the earth’s crust?

It’s not strictly a “solar system” mystery, but it does have cosmic significance. At the heart of it, Schmidt and Frank ask themselves: what is the likelihood that intelligent life on any planet – here or in the depths of space – will leave a mark, a sign that it once existed? ? And by the way: Hundreds of millions of years from now, will some extraterrestrial explorers landing on Earth be able to find traces of humans if we’re long gone?

Further reading: The Silurian hypothesis: would it be possible to detect an industrial civilization in the geological archives?


Can we push an asteroid off a collision course with Earth?

What if?
Tobias Roetsch/Future Publishing/Getty Images

Many disasters – volcanic eruptions, earthquakes, hurricanes, tornadoes – are unavoidable. Scientists talk about when, not if, they will strike. Although humans make some calamities worse, natural disasters have occurred long before we got here. They are part of life on Earth. But one type of disaster is not necessarily inevitable: a collision between an asteroid or a comet and the Earth.

The problem is this: we’ve never tried to deflect an asteroid and we don’t know if a plan to do so would work.

To help answer this question, NASA last year launched the Double Asteroid Redirection Test (DART), which is a car-sized box fitted with solar panels. It is currently en route to a 160 meter asteroid called Dimorphos. In the fall, DART will crash into Dimorphos at 24,000 kilometers per hour (about 15,000 miles per hour) in pursuit of a big question: Can the collision push the asteroid into an orbit? slightly different?

Further reading: The quest to avoid an asteroid apocalypse is going surprisingly well


Was there ever life on Mars?

The Perseverance Rover takes a selfie on Mars.
NASA/JPL-Caltech/MSSS

Mars today is a desert, devoid of any obvious signs of life. But over the years, scientists have uncovered evidence of a long-lost Mars that might have looked much more like Earth.

“Mars is a very different place today than it was 4 billion years ago, but you can see evidence of what it was,” says NASA astrobiologist Lindsay Hays. “You see things like the remnants of a huge river delta, which indicates not only that you had water flowing, but that you probably had a lot of water flowing over a long period of time that has continued to deposit sediment.”

And where there was water, there could have been life. Last year, a new rover landed on Mars, and this is our best chance to answer the question “was there ever life on Mars?” If the answer is “yes,” it could change our understanding of everyday life in the universe.

The Inexplicable episode on Mars aired June 22.

Further reading: NASA’s latest rover is our best chance of finding life on Mars


Is there a real ninth planet lurking in the darkness?

Pluto on July 13

Sorry, Pluto, there could be a new ninth planet.
NASA-JHUAPL-SWRI

In 2006, the International Astronomical Union voted to change the definition of what constitutes a planet, and Pluto was dropped. There were no longer nine official planets in the solar system, but eight.

But then “we started to realize that there really was something else out there – and a real giant planet that we think still lurks far beyond Neptune, waiting to be found”, said astronomer Mike Brown on Inexplicable. Astronomers haven’t detected this planet yet, but they suspect it’s there: other distant objects in the solar system appear to be impacted by its gravity.

Could these clues lead us to a real new ninth planet? Maybe. But it will be hard to find.

“It’s kind of like taking a little grain of black sand and throwing it on the beach,” Brown says of the research. “It would be a bit difficult to find that one in the sea of ​​all the others. And that’s the problem with Planet Nine.

Further reading: The Hunt for Planet 9


If you have ideas for topics for future shows, email us at unexplainable@vox.com.

]]>
Exercise may be helpful during cancer treatment https://michiganparanormalencounters.com/exercise-may-be-helpful-during-cancer-treatment/ Tue, 14 Jun 2022 20:52:22 +0000 https://michiganparanormalencounters.com/exercise-may-be-helpful-during-cancer-treatment/ Key points to remember Recent research has shown that exercise can help reduce the side effects of cancer treatment. Aerobic and resistance exercises have been shown to be particularly helpful for cancer patients. Experts say the findings are helpful because there has been no exercise advice for patients currently undergoing cancer treatments. The American Society […]]]>

Key points to remember

  • Recent research has shown that exercise can help reduce the side effects of cancer treatment.
  • Aerobic and resistance exercises have been shown to be particularly helpful for cancer patients.
  • Experts say the findings are helpful because there has been no exercise advice for patients currently undergoing cancer treatments.

The American Society of Clinical Oncology (ASCO) has made new exercise recommendations for patients undergoing cancer treatment, with an emphasis on aerobic and resistance exercise.

The guidelines are the first evidence-based recommendations for exercise and weight management during cancer treatment and suggest that physical activity may help alleviate some of the side effects of treatment.

“There are many guidelines for nutrition, exercise and weight management in to prevent cancer,” lead study author Jennifer Ligibel, MD, a medical oncologist at the Dana-Farber Cancer Institute, told Verywell. “But there is growing evidence that making changes during treatment could have an effect on how people behave during treatment.”

Exercise can reduce length of hospital stay

For the study published in the Journal of Clinical Oncology, the researchers analyzed 52 scientific journals: 42 related to exercise, nine to diet and one to weight management. They also included 23 randomized clinical trials in their analysis.

The most common types of cancer included in the studies were breast, prostate, lung and colorectal cancer.

Overall, the researchers found that exercising during cancer treatment helped patients improve their cardiorespiratory fitness, strength, and fatigue, among other benefits.

When lung cancer patients who exercised needed surgery, they spent less time in the hospital and had fewer complications than patients who did not exercise.

Based on these findings, ASCO decided to use the evidence to create exercise recommendations for patients currently being treated for cancer.

Is exercise okay for cancer patients?

Experts say the new evidence-based guidelines will help fill a gap in recommendations for people with cancer.

Jennifer Ligibel, MD

There is growing evidence that making changes during treatment could have an effect on how people behave during treatment.

—Jennifer Ligibel, MD

“There has never been a guideline that specifically focused on people undergoing chemotherapy, radiation therapy and perioperative treatments,” Ligibel said.

Catherine M. Alfano, PhD, one of the study’s co-authors and vice president of cancer care management and research at Northwell Health Cancer Institute, told Verywell that it’s information that patients want and need to know.

“Being treated for cancer makes many patients feel like they have no control over their health and this loss of control makes them very anxious,” Alfano said. “Patients are looking for things they can do to regain control and improve their long-term health and well-being while on treatment.”

Exercise and diet for cancer patients

The new guidelines address both exercise and diet considerations for people currently receiving cancer treatment.

The committee suggested that oncology providers recommend aerobic and resistance exercise to patients during treatment to reduce side effects associated with cancer treatments.

These exercises can have great benefits for those undergoing surgery for lung cancer, in particular.

“[Providers should] recommend preoperative exercises for patients who are scheduled for surgery for lung cancer, as this may reduce [the] length of hospital stay as well as postoperative complications,” Alfano said.

On the diet side, researchers did not find enough evidence to recommend or against keto or low-carb diets, low-fat diets, functional foods, or fasting diets for cancer patients.

Alfano said there was also not “sufficient evidence to support a recommendation for or against intentional interventions focused on weight loss or prevention of weight gain during active therapy in patients with cancer”.

How do aerobic and resistance exercises help cancer patients?

The study didn’t examine why aerobic and resistance training might be helpful — it only found a link between exercise and fewer side effects and better outcomes for cancer patients.

That said, experts have speculations about how aerobic and resistance exercise might benefit people being treated for cancer.

Nathan Parker, PhD, MPH, a researcher in the Department of Health Outcomes and Behavior at Moffitt Cancer Center, told Verywell that “both exercise modalities are very important, and together they provide the stimuli that the body needs. needs to improve or maintain health and well-being. -being.”

In general, Parker stated that “aerobic exercise will do more for improving or maintaining cardiorespiratory fitness, and resistance training will do more for muscle strength and maintaining lean body mass.”

It doesn’t have to be one or the other, though – Parker added that there are definitely “areas where the benefits of aerobic and resistance training overlap and synergize, c That’s why both contribute to a well-balanced exercise program.”

Scherezade K. Mama, DrPH, assistant professor of health disparities research at the University of Texas MD Anderson Cancer Center, told Verywell that aerobic and resistance exercise “also helps reduce inflammation, comorbidities such as cardiovascular disease and diabetes, and frailty, which helps manage side effects of treatment, such as nausea and fatigue, and reduces the likelihood of hospitalization during treatment.

Why advice is needed

Physical exercise is important to offset the negative effects of cancer treatment as much as possible.

“Cancer and cancer treatments can lead to losses in aerobic capacity and muscle strength and endurance,” Parker said. “They can also lead to detrimental changes in body composition – losing lean body mass, sometimes while gaining or maintaining fat – and they involve symptoms and side effects that pose challenges to daily living, such as fatigue and neuropathy.”

Nathan Parker, PhD MPH

Exercising to improve outcomes during cancer treatment is empowering.

—Nathan Parker, PhD MPH

According to Parker, these changes can make it difficult to tolerate cancer treatments. But exercise “can help reverse or alleviate these challenges, helping people tolerate treatment and maintain their quality of life during and beyond cancer treatment.”

Physical activity can also help patients cope emotionally with cancer treatments.

“Exercise to improve outcomes during cancer treatment is empowering because it is something within the control of the individual that can help improve outcomes at a time when many things can feel out of control. “, Parker said.

Although exercise during cancer treatments is generally recommended, Ligibel said patients should discuss with their providers what’s right for them, especially if they’re considering starting a new exercise program.

What this means for you

If you are currently undergoing cancer treatment, ask your oncologist about exercising during your treatment. New research has shown that it can help reduce the side effects of treatment and help you cope.

]]>
The gut microbiome could be the ‘black box’ of nutritional research https://michiganparanormalencounters.com/the-gut-microbiome-could-be-the-black-box-of-nutritional-research/ Mon, 13 Jun 2022 04:21:00 +0000 https://michiganparanormalencounters.com/the-gut-microbiome-could-be-the-black-box-of-nutritional-research/ In a recent article published in the Cell journal, researchers from the University of Alberta, Canada, and University College Cork, Ireland, analyzed current nutritional guidelines for the gut microbiota. Conclusion: Rethinking healthy eating in light of the gut microbiome. Image Credit: Kateryna Kon/Shutterstock Background Food is essential to human health and to the pathogenesis of […]]]>

In a recent article published in the Cell journal, researchers from the University of Alberta, Canada, and University College Cork, Ireland, analyzed current nutritional guidelines for the gut microbiota.

Conclusion: Rethinking healthy eating in light of the gut microbiome. Image Credit: Kateryna Kon/Shutterstock

Background

Food is essential to human health and to the pathogenesis of chronic non-communicable diseases at the epidemic level. The steady increase in chronic disease among non-industrialized populations converting to Western-style diets is striking testimony to the far-reaching influence of diet on human health.

Evidence-based dietary advice is essential for health promotion, given the global epidemic of diet-related chronic diseases. Although the human gut microbiota is of significant importance for the physiological consequences of diet and the genesis of chronic diseases, national dietary guidelines around the world are only beginning to take advantage of scientific advances in the microbiome sector.

Studies at the intersection of microbiome and nutrition disciplines have grown recently. Nevertheless, diet-microbiome-host relationships have received little attention in current dietary guidelines.

About the study

In this review, researchers approached current nutritional guidelines from the perspective of microbiome science, focusing on mechanistic findings that revealed host-microbe interactions as drivers of physiological impacts of diet. Scientists have narrowed their discussions of food-based dietary guidelines for health promotion and disease prevention among the general public, which is the goal of these guidelines.

The team focused on studies that showed how the gut microbiota regulates and facilitates the physiological impacts of food compounds, dietary habits and specific foods. They have used their findings to help clarify nutrition debates, create innovative nutritional advice, and provide an experimental paradigm for integrating the microbiome into nutritional research.

Interactions between gut microbiota and recommended foods

The authors found that the national dietary guidelines of many countries with varying dietary traditions exhibit a high level of consistency. These guidelines were in line with other major nutrition platforms, such as the EAT-Lancet Commission on Healthy Diets and Sustainable Food Systems and the Harvard TH Chan School of Public Health.

All of the dietary guidelines recommended whole plant-based foods like fruits, vegetables, legumes, whole grains and nuts instead of processed foods with added salt, saturated fats or sugar. Dietary fiber and phytochemicals comprise two essential components of whole plant foods.

Rapidly fermentable elements in processed foods could induce excessive growth of bacteria in the small intestine and an undesirable microbial metabolic and compositional profile. In addition, having a negative impact on the immune and endocrine systems. However, the colonic microbiota does not have access to it.

The evidence for the ability of whole grains to reduce the risk of chronic disease was strong, and the function of gut bacteria in these effects was increasingly studied. According to a study combining human research and mechanistic evaluations in mice, the microbiota may have a causal role in the health impacts of whole grains.

Several dietary standards advise frequent ingestion of plant-based protein foods because of their benefits to human and planetary health. A growing body of research indicates that the gut microbiome likely plays a role in the health benefits of legumes. Additionally, strong evidence from observational and interventional studies shows that a high intake of oily fish has a cardioprotective effect and that gut flora may be the source of these health benefits.

mediterranean diet

The Mediterranean diet incorporates many types of foods that have a favorable impact on interactions with the host. He advises fruits, vegetables, legumes, nuts, whole grains and olive oil as essential parts of the diet, a moderate consumption of eggs, poultry, fish and dairy products, and limited consumption of processed and red meats and processed foods.

Many recent microbiome studies reinforce the importance of the Mediterranean diet in dietary recommendations. Indeed, recently updated dietary guidelines advocate eating habits that reflect the Mediterranean diet, such as Dietary Approaches to Arrest Hypertension (DASH).

Food-microbe-host links on healthy eating controversies

Toxicological considerations explain the World Health Organization (WHO) or International Agency for Research on Cancer (IARC) expert group risk classification of red and processed meats, as well as existing dietary recommendations, based on probable dose-response correlations. Moreover, many mechanistic animal models highlight the potentially harmful impacts of saturated fats from milk on the homeostasis of the microbiota, reinforcing dietary recommendations to limit the consumption of high-fat dairy products.

It is uncertain whether the microbiota causally contributes to the acute metabolic consequences of low carbohydrate and low fat diets in humans. The authors noted that using microbiome-targeted techniques to improve low-carb diets would be beneficial.

Impact of gut microbiome on advancing nutritional recommendations

The team said dietary recommendations, targeted nutritional approaches and the development of food products to address chronic disease risk could benefit from considering how diet-microbiome interactions have influenced human physiology. It also laid the groundwork for initiatives to restore the microbiome. The microbiome restoration technique could theoretically be achieved with dietary synbiotics and probiotics.

It has been hypothesized that reformulation of processed foods, rather than eradication, would improve diet quality on a population scale. Such efforts will require a breakthrough in food engineering that addresses food-microbe-host interconnections.

The researchers mentioned that nutritional strategies could be used to target the microbiome and health-promoting taxa once their characteristics are recognized. Microbiome assessments were a critical part of precision nutrition methods focused on chronic disease prevention and treatment, among other individual-specific aspects, due to the highly personalized response of the gut microbiota to diet.

Experimental framework integrating the gut microbiome into nutritional investigations

Data on diet-microbiome-host relationships could improve, modify and innovate dietary recommendations. Integration of the gut microbiome into dietary recommendations should be supported by evidence of the causal and mechanistic contributions of the microbiome to the physiological impacts of diet.

The team referred to outstanding reviews that set the best practice standards for diet and microbiome studies and complemented them with a three-pillar experimental design incorporating the gut microbiome in all phases of research. nutritional. Microbiome findings to develop healthy diet hypotheses, microbiome integration in human intervention studies, and mechanistic understanding and causal inferences regarding microbiome function in diet impacts were among these pillars.

conclusion

According to the authors, the convergence of fundamental concepts in the areas of nutrition and microbiome confirms current dietary recommendations. They found that the systematic integration of microbiome knowledge into nutritional studies can further boost and revolutionize healthy eating.

Overall, the study findings indicated that diet was significantly linked to the absence or presence of disease, which subsequently related to the microbiome. Diet-microbiome connections were expected to contribute to the molecular basis of dietary physiological effects, making the gut microbiome the “black box” of nutritional studies. There is a compelling evolutionary and biological rationale for the two disciplines to expand their already extensive and persistent collaborations to learn more about how to improve health through diet.

The researchers said microbiome-focused endpoints need to be integrated into all facets of nutrition science to increase the scientific basis for dietary recommendations. Additionally, nutritional microbiology research can provide comprehensive information on all elements of a healthy diet. Thus, contributing to solving the problem of prevention and control of diet-related diseases.

]]>
The Washington Post Promotes Trump’s Other ‘Big Lie’: The Wuhan Lab Theory https://michiganparanormalencounters.com/the-washington-post-promotes-trumps-other-big-lie-the-wuhan-lab-theory/ Sat, 11 Jun 2022 03:25:05 +0000 https://michiganparanormalencounters.com/the-washington-post-promotes-trumps-other-big-lie-the-wuhan-lab-theory/ On Thursday, the Senate held a public hearing documenting how former President Donald Trump used his ‘big lie’ about the 2020 election to justify a fascist coup attempt, aimed at abolishing the peaceful transfer of power and turn the United States into a dictatorship. But that same day, the Washington Postpublished an op-ed promoting Trump’s […]]]>

On Thursday, the Senate held a public hearing documenting how former President Donald Trump used his ‘big lie’ about the 2020 election to justify a fascist coup attempt, aimed at abolishing the peaceful transfer of power and turn the United States into a dictatorship.

But that same day, the Washington Postpublished an op-ed promoting Trump’s other big lie: the claim that COVID-19 is a man-made virus created at China’s Wuhan Institute of Virology.

White House trade adviser Peter Navarro (right) called COVID-19 a “weaponized virus” created by the Chinese Communist Party. Trump repeatedly called COVID-19 Kung-Flu and the Chinese virus. (AP Photo/Alex Brandon)

The Job promotes the “hypothesis” that “the infection may have resulted from a laboratory accident or accidental spill linked to the Wuhan Institute of Virology”. He adds, “At the time, the WIV was conducting experiments using genetically engineered viruses similar to the pandemic strain.”

The Job presents his promotion of Trump’s racist effort to blame China for the COVID-19 pandemic as a statement that “two major hypotheses arose about how the virus first infected humans in Wuhan in late 2019 “.

It’s like saying that there are “two major hypotheses” on the validity of the results of the 2020 presidential election. No, there are none. There’s the truth, and there’s a right-wing conspiracy theory.

Trump’s claim that the 2020 election was stolen had no supporting evidence and was a transparent falsification. It does not require forensic examinations of voting machines, voting booths or voter records. Any politician or journalist who gives the slightest credence to this claim is a fascist sympathizer.

Trump’s election lie was concocted by Trump advisers Stephen K. Bannon, Peter Navarro, Jason Miller and their co-conspirators, organized around Bannon’s podcast, “War Room: Pandemic.” On January 5, the day before Trump’s coup attempt, Bannon said, “Hell is going to break loose tomorrow.”

Bannon’s podcast, however, was created to promote a different lie. On January 25, 2020, Bannon renamed his podcast “War Room: Impeachment” to focus on the claim that China created COVID-19 as a bioweapon to attack the United States. He called it “War Room: Pandemic”, which is his name to this day.

In the above photo, released by CNN, Wang DingGang, who appears to be behind the claim that COVID-19 was a man-made virus, is pictured with Trump lawyer Rudy Giuliani, while Bannon is shown in the background. Li-Meng Yan, a lab leak advocate who Bannon says was a “whistleblower”, is reflected in a mirror. Credit: CNN

In the first episode of the podcast, recorded on January 25, Bannon invited washington time columnist Bill Gertz to talk about an upcoming article (of which Bannon had advanced knowledge) claiming that “coronavirus may have originated from a lab linked to China’s biological warfare program”.

]]>
Satyendra Nath Bose: Google honors Indian scientist and mathematician Satyendra Nath Bose in today’s Doodle | India News https://michiganparanormalencounters.com/satyendra-nath-bose-google-honors-indian-scientist-and-mathematician-satyendra-nath-bose-in-todays-doodle-india-news/ Sat, 04 Jun 2022 04:19:00 +0000 https://michiganparanormalencounters.com/satyendra-nath-bose-google-honors-indian-scientist-and-mathematician-satyendra-nath-bose-in-todays-doodle-india-news/ NEW DELHI: Satyendra Nath Bose, an Indian scientist and mathematician, is honored in today’s doodle for his contribution to the Bose-Einstein condensate. He delivered his quantum formulations to Albert Einstein that day in 1924, and Einstein immediately recognized it as a key breakthrough in quantum mechanics. Bose’s rise to fame began in academia. Bose’s enthusiasm […]]]>
NEW DELHI: Satyendra Nath Bose, an Indian scientist and mathematician, is honored in today’s doodle for his contribution to the Bose-Einstein condensate. He delivered his quantum formulations to Albert Einstein that day in 1924, and Einstein immediately recognized it as a key breakthrough in quantum mechanics.
Bose’s rise to fame began in academia. Bose’s enthusiasm for math was stifled by his father, an accountant, who created an arithmetic assignment for him to answer every day before going to work. Bose began studying for a Bachelor of Science degree at Presidency College, Calcutta at the age of 15, then earned a Masters in Applied Mathematics at the University of Calcutta. He confirmed his prestigious academic status by obtaining the top of his class for both degrees.
By late 1917, Bose had begun offering physics lectures. While teaching Planck’s radiation formula to graduate students, he began to doubt how particles were measured and began testing his own hypotheses. He published his findings in a study titled Planck’s Law and the Hypothesis of Light Quanta, which he submitted to The Philosophical Magazine, a prestigious research magazine. His research was denied, much to his astonishment. He made the brave choice to send his manuscript to Albert Einstein at this time.
Einstein indeed recognized the significance of the discovery and quickly applied Bose’s formula to a wide range of phenomena. Bose’s theoretical paper has become one of the most important discoveries in quantum theory. The Indian government recognized Bose’s enormous contribution to physics by awarding him one of the country’s highest civilian honours, the Padma Vibhushan. He was also appointed a National Professor, India’s highest honor for scholars.
A true polymath, Bose went on to serve as president of many scientific institutions including the Indian Physical Society, National Institute of Science, Indian Congress of Science and Indian Statistical Institute. He was also an adviser to the Council for Scientific and Industrial Research and later became a Fellow of the Royal Society. In honor of Bose’s legacy, any particle that conforms to his statistics today is known as a boson. Many scientific breakthroughs resulted from his work, including the discovery of the Particle Accelerator and the God Particle.
Thank you, Satyendra Nath Bose, for changing physics forever. Your discovery has put quantum mechanics on a loop!
]]>
The James Webb Space Telescope is about to study two strange super-Earths https://michiganparanormalencounters.com/the-james-webb-space-telescope-is-about-to-study-two-strange-super-earths/ Fri, 03 Jun 2022 16:46:56 +0000 https://michiganparanormalencounters.com/the-james-webb-space-telescope-is-about-to-study-two-strange-super-earths/ The James Webb Space Telescope plans to explore strange new rocky worlds in unprecedented detail. The telescope science consortium has an ambitious program to study the geology of these small planets “50 light-years away”, they said in a statement Thursday, May 26. The work will be extensive for the new observatory, which should come into […]]]>

The James Webb Space Telescope plans to explore strange new rocky worlds in unprecedented detail.

The telescope science consortium has an ambitious program to study the geology of these small planets “50 light-years away”, they said in a statement Thursday, May 26. The work will be extensive for the new observatory, which should come into service in a few weeks.

Rocky planets are more difficult to see than gas giants in current telescope technology, due to the relative brightness of the smallest planets next to a star and their relatively small size. But Webb’s powerful mirror and deep-space location should allow him to examine two planets slightly larger than Earth, called “super-Earths.”

None of these worlds are habitable as we know them, but studying them could still be a testing ground for future in-depth studies of planets like ours. The two planets highlighted by Webb officials include 55 Cancri e, which is super hot and covered in lava, and LHS 3844 b, which has no substantial atmosphere.

55 Cancri e orbits its parent star 1.5 million miles (2.4 million km), or about four percent of the relative distance between Mercury and the sun.

Revolving around its star just once every 18 hours, the planet has blast-furnace surface temperatures above the melting point of most rock types. Scientists have also assumed the planet is tidally locked to the star, meaning one side always faces the scorching sun, although observations from NASA’s Spitzer Space Telescope suggest the hottest area could be slightly offset.

Scientists say the offset heat could be due to a thick atmosphere that can move heat around the planet, or because lava rains down at night in a process that removes heat from the atmosphere. (Nocturnal lava also suggests a day-night cycle, which could be due to a 3:2 resonance, or three rotations for two orbits, that we see on Mercury in our own solar system.)

Two teams will test these hypotheses: one led by research scientist Renyu Hu of NASA’s Jet Propulsion Laboratory will examine the planet’s thermal emission for signs of an atmosphere, while a second team led by Alexis Brandeker, an associate professor at Stockholm University, will measure the heat emittance of the illuminated side of 55 Cancri e.

LHS 3844 b is also a near orbiter, circling its parent star just once every 11 hours. The star, however, is smaller and cooler than that of 55 Cancri e. Thus, the planet’s surface is likely much cooler, and Spitzer’s observations have shown that there is probably no substantial atmosphere present on the planet.

A team led by astronomer Laura Kreidberg of the Max Planck Institute for Astronomy hopes to pick up a signal from the surface using spectroscopy, in which different wavelengths of light suggest different elements. Thermal emission spectra from the daylight side of the planet will be compared to known rocks like basalt and granite to see if they can infer a surface composition.

The two surveys “will give us fantastic new insights into Earth-like planets in general, helping us understand what early Earth was like when it was warm like these planets are today,” Kreidberg said in the same communicated.

Webb is currently working on late-stage commissioning procedures, such as tracking targets in the solar system and moving between warmer and cooler attitudes to test his mirror strength and instrument alignment. The $10 billion observatory is expected to complete commissioning around June and move into its Cycle 1 of observations shortly thereafter.

Copyright 2022 Space.com, a company of the future. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

]]>
Antibody-Drug Conjugates Could Be the Future of HER2-Low Breast Cancer Treatment https://michiganparanormalencounters.com/antibody-drug-conjugates-could-be-the-future-of-her2-low-breast-cancer-treatment/ Wed, 01 Jun 2022 18:51:30 +0000 https://michiganparanormalencounters.com/antibody-drug-conjugates-could-be-the-future-of-her2-low-breast-cancer-treatment/ Emerging data on novel antibody-drug conjugates (ADCs) such as trastuzumab deruxtecan-nxki (Enhertu), vic-trastuzumab duocarmazine and disitamab vedotin (Aidixi) show encouraging activity in low HER2 breast cancer. Paolo Tarantino, MD, said these data suggest that the classification of HER2 should go beyond just positive or negative. “Going forward, we will need to evolve our understanding and […]]]>

Emerging data on novel antibody-drug conjugates (ADCs) such as trastuzumab deruxtecan-nxki (Enhertu), vic-trastuzumab duocarmazine and disitamab vedotin (Aidixi) show encouraging activity in low HER2 breast cancer. Paolo Tarantino, MD, said these data suggest that the classification of HER2 should go beyond just positive or negative.

“Going forward, we will need to evolve our understanding and classification of HER2,” he said.

In an interview with Live®, Tarantino, a clinical researcher at the Dana-Farber Cancer Institute, described current methods for measuring and treating HER2-low breast cancer, discussed drug development challenges, and talked about upcoming trial data phase 3 DESTINY-Breast04 (NCT03734029). Data from this trial showed that patients with pretreated HER2-low tumors derive clinical benefit from trastuzumab deruxtecan.

Tarantino also expressed his hopes for the future of advances in the treatment of HER2-positive disease. He noted that expanding the classification of HER2 disease to include more patient subgroups, such as those with an immunohistochemistry (IHC) score of 0 in clinical trials, could help determine potential benefits. treatment for a greater proportion of patients.

Live®: What is important to know about the field of HER2-low breast cancer?

Tarantino: It is important to look back, because for 20-25 years we have been categorizing HER2 as a binary [protein], as HER2-negative or HER2-positive. Indeed, when trastuzumab [Herceptin], the first HER2 inhibitor, has been developed, it has shown clinical benefit in patients with HER2 positive tumors, which account for 15-20% of all breast cancers. However, when trastuzumab was tested in tumors with low HER2 expression, it provided no clinical benefit.

The NSABP-B-47 Phase 3 trial [NCT01275677] random [3270] adjuvant trastuzumab patients. Again, trastuzumab did not improve outcomes in the HER2-low population for disease-free survival or overall survival [OS]. These results have recently changed with the development of new ADCs.

What is HER2-low disease and how is it currently measured?

The classification for HER2-weak that is used in most clinical trials [means] tumors that have an IHC expression of 1+ or 2+ with negative in situ hybridization [ISH] test. [These are tumors] without the amplification of ERBB2 oncogene. With this definition, approximately half of all breast tumors can be defined as HER2 low.

However, this definition is changing over time. In the patient population with an IHC score of 0, we have tumors with minimal expression of HER2. Today, we call these ultra-low expressors HER2. Patients with these tumors are included in some trials, for example the phase 3 randomized trial DESTINY-Breast06 [NCT04494425]. In the future, we will know if, in this category, new ADCs can have an activity, but for the moment, the definition [of HER2-low] which is mainly used is IHC 1+ or 2+ with negative ISH.

Does the evolution of this definition complicate clinical development and progress?

Absolutely, very difficult. Our main challenge is that this definition is based on these low categories of IHC, which were not really standardized. Previously, the question was whether a tumor could be classified as 3+ or 2+, and there was little need in clinical practice to distinguish score 0 from score 1+. And now we have this need, because [these scores] may alter the potential recruitment of patients into clinical trials and potentially alter the clinical possibilities open for future new drugs.

It becomes a problem because there are some studies, such as a yale study, showing that there is very little agreement between pathologists when reading slides with very low HER2 expression. In the future, we may need more standardization and possibly new tests for HER2.

Could you explain why the historic results have created a need for better drug development for patients with low HER2 breast cancer?

HER2-low is a heterogeneous category. It is mainly composed of 2 entities, 1 being a hormone receptor [HR]– positive tumors, which are usually luminal tumors that are treated with endocrine therapy, chemotherapy and certain biological treatments such as CDK4/6 inhibitors. However, for endocrine-resistant tumours, the main treatment is generally based on several lines of chemotherapy, and the results of these chemotherapies are not excellent. There is an unmet need for new treatments.

[The other category of HER2-low disease, triple-negative breast cancer (TNBC), has similar treatment methods. TNBC is] also primarily treated with chemotherapy, although new options are emerging, such as immunotherapy or other ADCs targeting TROP2. However, after these patients were treated with immunotherapy or TROP2 [inhibitors], we only have chemotherapy for these patients. Again, we need new options.

Moreover, most HER2-low tumors also co-express hormone receptors. Most HER2-low tumors will also be HR positive… About a third of triple negative breast tumors will have HER2-low expression.

Some of the drugs being developed in HER2-low breast cancer include trastuzumab deruxtecan, trastuzumab duocarmazine, and disitamab vedotin. What makes these drugs exciting?

These are all evolutions of ado-trastuzumab emtansine [Kadcyla], which was the first HER2-driven ADC to be approved. Trastuzumab emtansine is a drug we’ve been using for a long time, and it’s an active drug. The idea is that it delivers a chemotherapy payload to the tumor cell, targeting HER2.

The newer ADCs, compared to trastuzumab emtansine, have some technical improvements and they generally have a higher drug-to-antibody ratio. For example, trastuzumab deruxtecan has 8 payload molecules versus 3.5 molecules with trastuzumab emtansine. Additionally, most new ADCs have cleavable linkers and membrane diffusible payloads, allowing for what we call the bystander effect. This means that in tumors with heterogeneous HER2 expression, the payload can fuse to non-HER2-expressing cells and cause control death.

These hypotheses suggest that these effects might show activity in HER2-low tumors. In fact, we saw that when trastuzumab emtansine was tested in HER2-low breast cancer, the response rate was around 5%. It was not satisfactory. But with all these new agents, such as trastuzumab deruxtecan, trastuzumab duocarmazine and disitamab vedotin, we have a response rate of around 30% to 40%, which is much more interesting and encouraging.

[We now also have a press release announcing data from the phase 3 DESTINY-Breast-04 trial], suggesting that these drugs could come to the clinic. DESTINY-Breast04 was the first phase 3 trial to confirm the low HER2 paradigm. Basically, this trial included patients with pretreated HER2-low tumors, with both HR-positive and triple-negative disease. Patients were required to have received at least 1 or 2 lines of chemotherapy, and they were randomized to receive trastuzumab deruxtecan or chemotherapy of physician’s choice.

The Press release reported that progression-free survival, which was the primary endpoint, and OS were improved with trastuzumab deruxtecan compared with chemotherapy. We will see this data presented at the 2022 ASCO Annual Meeting and the 2022 EHA Congress. This data could change the way we treat patients who have been chemotherapy pretreated with or without endocrine therapy.

What do you hope the DESTINY-Breast04 results will show in terms of safety?

This agent has been tested in several trials now. What we’ve seen in early phase 1 trials with trastuzumab deruxtecan is that it’s a manageable agent. Most of the adverse effects were haematological or gastrointestinal toxicity, ie nausea or vomiting, but generally of low intensity.

In these early trials, we also observed a 10% to 15% rate of interstitial lung disease [ILD]. This was concerning because there were fatal effects. However, with other trials, especially the DESTINY-Breast03 trial [NCT03529110], which was a randomized study in HER2-positive disease. We have seen that when we improve our detection and management of ILDs, there is [fewer] serious cases and no fatal cases. In DESTINY-Breast03 there was approximately 10% ILD rate and no Grade 4 or 5 adverse reactions [AEs]. This means that we learn to better manage [the toxicities with] this officer.

I would expect the AE profile in the DESTINY-Breast04 trial to be similar to what we saw in DESTINY-Breast03, which would mean that trastuzumab deruxtecan is a manageable agent.

If trastuzumab deruxtecan, trastuzumab duocarmazine and disitamab vedotin are all advancing in development and showing positive phase 3 data, do you see each agent carving out a role in this population?

[The answer to this question] goes beyond HER2-directed ADCs. Another big news in HER2-low disease is that the TROPiCS-02 Phase 3 trial [NCT03901339] is positive, meaning that sacituzumab govitecan-hziy [Trodelvy], a TROP2 inhibitor ADC that is approved in triple-negative disease, is also more active than chemotherapy in HR-positive disease. In this pretreated population, we might have different ADCs available and we might need to decide which one to prioritize.

We don’t really know if one is active after the other, but we may collect this data in the months and years to come. For now, we may need to make comparisons between trials, [which, though not ideal are sometimes necessary when choosing treatments]. Presentation of data from DESTINY-Breast04, TROPiCS-02 and other trials with disitamab vedotin and trastuzumab duocarmazine [will help us understand the roles of these agents going forward].

What other insights into the future of HER2-low breast cancer would you like to offer?

One trial that shocked the scientific community with its scientific significance, even though it only studied a small cohort of patients, is the DAISY Phase 2 trial. [NCT04132960]. This is a study conducted in France that tested trastuzumab deruxtecan in patients with advanced breast cancer, regardless of HER2 expression.

The DAISY trial had a HER2 positive cohort where the drug was highly active, showing a rate of 69.1% [best objective] answer [BOR] rate, which is what we’ve seen in other trials in HER2-positive disease. This trial also had a HER2-weak cohort where we observed a BOR rate of 33.3%, which we had observed in other phase 1 trials. This trial also had a cohort of patients with an IHC score of 0 , a cohort we’ve never seen before. This cohort demonstrated a [30.6%] response rate, which is unexpected and raises many questions as to the best categorization of HER2. With 1+ or 2+ ISH-negative disease categorization, we may be excluding patients who might benefit from trastuzumab deruxtecan.

[We also want to know] why trastuzumab deruxtecan had activity in patients with IHC scores 0. Is it because there is minimal expression of HER2, even in this population? Or is it because the diffusing payload that detaches from the antibody may still have antitumor effects? These are all open questions. It will be important to investigate these issues in depth, particularly because there could be a population that is currently excluded from treatment with trastuzumab deruxtecan, but may still benefit from it.

]]>
The James Webb Space Telescope will study two strange “super-Earths” https://michiganparanormalencounters.com/the-james-webb-space-telescope-will-study-two-strange-super-earths/ Mon, 30 May 2022 18:00:59 +0000 https://michiganparanormalencounters.com/the-james-webb-space-telescope-will-study-two-strange-super-earths/ The James Webb Space Telescope plans to explore strange new rocky worlds in unprecedented detail. The telescope science consortium has an ambitious program to study the geology of these small planets “50 light-years away”, they said in a statement Thursday, May 26. The work will be extensive for the new observatory, which should come into […]]]>

The James Webb Space Telescope plans to explore strange new rocky worlds in unprecedented detail.

The telescope science consortium has an ambitious program to study the geology of these small planets “50 light-years away”, they said in a statement Thursday, May 26. The work will be extensive for the new observatory, which should come into service in a few weeks.

]]>